Celldex Therapeutics, Inc.
CLDX
$41.95
-$0.66-1.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 717.59M | 451.46M | 518.57M | 583.22M | 630.34M |
| Total Receivables | 230.00K | 230.00K | 2.02M | 90.00K | 90.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.11M | 7.53M | 14.08M | 21.03M | 17.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 724.93M | 459.22M | 534.66M | 604.34M | 648.40M |
|
|
|||||
| Total Current Assets | 724.93M | 459.22M | 534.66M | 604.34M | 648.40M |
| Net Property, Plant & Equipment | 14.79M | 9.41M | 7.77M | 7.55M | 7.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.43M | 15.43M | 13.36M | 9.36M | 9.30M |
| Total Assets | 782.35M | 511.25M | 582.98M | 648.44M | 692.41M |
|
|
|||||
| Total Accounts Payable | 14.68M | 10.36M | 1.18M | 4.27M | 2.07M |
| Total Accrued Expenses | 43.86M | 38.42M | 47.03M | 39.72M | 28.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.56M | 1.47M | 1.55M | 1.55M | 1.54M |
| Total Finance Division Other Current Liabilities | 1.23M | 1.23M | 1.23M | 930.00K | 930.00K |
| Total Other Current Liabilities | 1.23M | 1.23M | 1.23M | 930.00K | 930.00K |
| Total Current Liabilities | 61.33M | 51.47M | 50.99M | 46.47M | 32.96M |
|
|
|||||
| Total Current Liabilities | 61.33M | 51.47M | 50.99M | 46.47M | 32.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.35M | 443.00K | 784.00K | 1.07M | 1.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.11M | 3.11M | 4.04M | 2.54M | 2.54M |
| Total Liabilities | 67.79M | 55.03M | 55.82M | 50.08M | 37.00M |
|
|
|||||
| Common Stock & APIC | 2.68B | 2.35B | 2.34B | 2.33B | 2.32B |
| Retained Earnings | -1.97B | -1.89B | -1.81B | -1.73B | -1.67B |
| Treasury Stock & Other | 1.30M | 2.52M | 3.63M | 3.77M | 3.34M |
| Total Common Equity | 714.56M | 456.23M | 527.17M | 598.36M | 655.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 714.56M | 456.23M | 527.17M | 598.36M | 655.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 714.56M | 456.23M | 527.17M | 598.36M | 655.41M |
|
|
|||||